Methods for treating ischemic tissue
Compositions and methods for treating ischemic tissue are provided herein.
1 . (canceled)
2 . A method, comprising: contacting an ischemic tissue concurrently with at least a first cultured three-dimensional tissue, wherein the cultured three-dimensional tissue is in an amount sufficient to promote one or more biological activities associated with the healing of ischemic tissue.
3 . The method of claim 2 , in which the ischemic tissue is further contacted with at least a second cultured three-dimensional tissue.
4 . The method of claim 2 , wherein the cultured three-dimensional tissue is in an amount sufficient to reduce or prevent tissue remodeling associated with ischemia.
5 . The method of claim 2 , further comprising attaching the cultured three-dimensional tissue to the ischemic tissue using a degradable or non-degradable suture, a biologic glue, a synthetic glue, a laser dye, a hydrogel, or by cellular attachment.
6 . The method of claim 2 in which the ischemic tissue is heart tissue.
7 . The method of claim 6 in which the ischemia is reversible.
8 - 11 . (canceled)
12 . The method of claim 6 in which the cultured three-dimensional tissue is in an amount sufficient to improve the ejection fraction of the treated heart.
13 . The method of claim 6 in which the ischemic heart tissue is contacted with a first and at least second cultured three-dimensional tissues.
14 - 15 . (canceled)
16 . A method of improving the ejection fraction of a diseased heart comprising contacting an ischemic region of the diseased heart with an effective amount of a cultured three-dimensional tissue.
17 . A method of treating a patient suffering from coronary artery disease comprising contacting an ischemic region of the patient's heart with an effective amount of a cultured three-dimensional tissue.
18 . A method of treating a patient suffering from left ventricular dysfunction and reversible myocardial ischemia comprising contacting an ischemic region of the patient's heart with an effective amount of a cultured three-dimensional tissue.
19 . The method of claim 16 in which the effective amount of the cultured three-dimensional tissue is sufficient to induce angiogenesis in the ischemic heart tissue.
20 . The method of claim 16 in which the effective amount of the cultured three-dimensional tissue is sufficient to improve the ejection fraction of the diseased heart.
21 . The method of claim 16 in which the ischemic heart tissue is contacted with a first and at least a second cultured three-dimensional tissue.
22 . (canceled)
23 . The method of claim 2 in which the cultured three-dimensional tissue comprises fibroblasts.
24 - 25 . (canceled)
26 . The method of claim 25 in which the vascular smooth muscle cells are aortic smooth muscle cells.
27 . The method of claim 2 in which the cultured three-dimensional tissue comprises cardiac muscle cells.
28 . The method of claim 2 in which the cultured three-dimensional tissue comprises stem cells.
29 . The method of claim 2 in which the cultured three-dimensional tissue comprises a plurality of cell types, each of the plurality of cell types independently selected from the group consisting of fibroblasts, smooth muscle cells, cardiac muscle cells, endothelial cells, mesenchymal stem cells, pericytes, macrophages, monocytes, leukocytes, plasma cells, mast cells and/or adipocytes.
30 - 34 . (canceled)
35 . The method of claim 2 in which the cells of the cultured three-dimensional tissue are attached to a scaffold comprising a degradable material.
36 . The method of claim 35 in which the degradable material comprises polyglycolic acid, polylactide, polylactide-co-glycolic acid, catgut sutures, cellulose, gelatin, collagen, or dextran.
37 - 43 . (canceled)